MDM4 at the Crossroads: Beyond p53 and MDM2.

Area of Science:

• Oncology
• Molecular Biology
• Cellular Biology

Background:

• MDM4 (Murine Double Minute 4) is a key negative regulator of the tumor suppressor p53.
• MDM4 collaborates with MDM2 to degrade p53, promoting tumor development.
• Emerging evidence highlights MDM4's significant p53-independent functions.

Purpose of the Study:

• To elucidate the diverse p53-independent roles of MDM4.
• To explore MDM4's interactions with various proteins beyond the p53-MDM2 axis.
• To understand MDM4's implications in cancer biology and therapeutic development.

Main Methods:

• Literature review and analysis of existing studies on MDM4.
• Identification of MDM4 interacting partners and their functional consequences.
• Comparative analysis of MDM4's roles in both p53-dependent and p53-independent pathways.

Main Results:

• MDM4 regulates cell cycle, pre-leukemic progression, and ferroptosis via p53-independent interactions (e.g., with p73, E2F1, TRIM21).
• MDM4 also controls proliferation, survival, DNA repair, and replication fork progression independently of p53 and MDM2 through interactions with SMADs, pRB, Nbs1, and mTORC1.
• MDM4 exhibits context-dependent oncogenic or tumor-suppressive activities independent of p53.

Conclusions:

• MDM4's biological functions extend significantly beyond its canonical role in inhibiting p53.
• MDM4's complex interactions and dual roles in cancer necessitate further investigation.
• Targeting MDM4 may offer novel therapeutic strategies for various cancers.